Genomtec Documents
Documents
0
Ticker
GMT.WA
ISIN
PLGNMTC00017
Genomtec SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Genomtec Documents 2026
This page contains all official documents and SEC filings for Genomtec stock (GMT.WA, ISIN: PLGNMTC00017). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Genomtec's regulatory filings.
Genomtec Stock analysis
Genomtec Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments.